Drug Profile
Research programme: eye disorders therapy - Debiopharm
Alternative Names: DEBIO-88; UNIL 88Latest Information Update: 09 Mar 2009
Price :
$50
*
At a glance
- Originator Debiopharm
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Dry eyes
Most Recent Events
- 09 Mar 2009 Discontinued - Preclinical for Dry eyes in Switzerland (unspecified route)
- 27 Aug 2003 Preclinical trials in Dry eyes in Switzerland (unspecified route)